Therapeutical Options For Optimizing The Glycemic Profile In A Patient With T2DM
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2010, Vol 17, Issue 4
Abstract
Incretin-based therapies address some of the mechanisms of T2DM by improving β-cell function, inhibiting glucagon secretion, stimulating insulin secretion, reducing appetite and promoting weight loss. We present the case of a patient with type 2 diabetes mellitus who was admitted in the Diabetes, Nutrition and Metabolic Diseases Clinic for high blood glucose values and polyuria. Because the patient had high glycemic values during self-monitoring of blood glucose (SMBG) and also symptoms of hypoglycemia, we decided to evaluate the glycemic variability using the recordings of the continuous glucose monitoring system (CGMS). The CGMS indicated that the patient had episodes of hypoglycemia and also high glucose values. The treatment was changed and the therapy with exenatide was initiated together with reinforcement of lifestyle optimization. The CGMS and SMBG three months after the treatment change indicated the improvement of glycemic control, weight reduction and cardiovascular risk reduction. The GLP-1 receptor agonists are a very good therapeutical option in subjects with T2DM where the HbA1c value is not very high, the duration of T2DM is small, weight loss is a very important issue and there is a high risk of hypoglycemia.
Authors and Affiliations
Ilie-Robert Dinu, Simona Georgiana Popa, Maria Mota, Eugen Mota, Dumitru Lacatis
Keywords
Related Articles
- EP ID EP129422
- DOI -
- Views 87
- Downloads 0
ANKLE BRACHIAL PRESSURE INDEX, VALUE AND LIMITATIONS CONSIDERATIONS ABOUT ITS APPLICABILITY FOR DIABETIC INDIVIDUALS
Non-invasive ultrasound investigations are frequently used as a screening maneuver for peripheral vascular disease. The ankle to brachial pressure index (ABPI) it is a noninvasive hand-held Doppler test that is able to p...
THE RELATIONSHIP BETWEEN 1 HOUR GLYCEMIA, DURING ORAL GLUCOSE TOLERANCE TEST AND CARDIOMETABOLIC RISK
Background Diabetes mellitus is a very common disease, worldwide there are currently over 366 million diabetics. It seems that people with normal glucose tolerance and blood glucose at 1 hour during OGTT ≥200mg% re...
VITAMIN D DEFICIENCY EFFECTS UPON DIABETES MELLITUS AND ITS CARDIOVASCULAR AND RENAL CHRONIC COMPLICATIONS
Vitamin D was proved to have multiple non-skeletal actions, its receptor being expressed by almost every tissue, consequently proper levels being necessary for their optimal functioning. Although biologically inactive, 2...
THE EPIDEMIOLOGY OF DIABETIC NEUROPATHY
One of the major complications of diabetes mellitus (DM) is represented by the diabetic neuropathy (DN). Different peripheral nerves may be affected through many pathological processes and, therefore, there are many type...
A DISEASE CAN BE NEITHER HEALTHY, NOR BENIGN